Given both the rarity and unique morphology of tau-positive GGIs, we wanted to determine the specific properties that differentiate pathological tau species in GGT from abnormal forms of tau in more common tauopathies, such as AD, PSP, and CBD. The gene discussed is MAPT; the disease is supranuclear palsy, progressive, 1.